00019N050D0 IN111 pentetreotide octreosc

Ended Awarded Last action

Contract number
HT001416F0218
Awardee
Awarding agency
Obligated
$125,090

Award facts

Contract value 100% obligated
$125,090.46 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Hazelwood, MO 63042, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 -$7,394
Other Administrative Action P00002 $0
Funding Only Action P00001 $132,485
Original award $0

About this award

This is a delivery order awarded by the Defense Health Agency (DHA) to Mallinckrodt LLC, a foreign-owned for-profit organization, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is for the delivery of Pentetreotide Octreoscan, a pharmaceutical product, with a ceiling value of $125,090.46 and a period of performance ending on September 30, 2017. The contract is a firm fixed-price type and does not have a set-aside designation.

Quick answers

Who was awarded contract HT001416F0218?

HT001416F0218 was awarded to Mallinckrodt LLC by Defense Health Agency (Department of Defense) on October 1, 2016.

How much is contract HT001416F0218 worth?

The government has obligated $125,090 on HT001416F0218.

Is contract HT001416F0218 an order under another contract?

Yes. HT001416F0218 is a delivery order under V797P5027B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract HT001416F0218 competed?

The extent of competition for HT001416F0218 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award